Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 20 (1), 120-129
- https://doi.org/10.1038/modpathol.3800712
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease ProgressionJournal of Clinical Oncology, 2004
- Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junctionMolecular Pathology, 2003
- Molecular Genetic Changes in Metastatic Primary Barrett's Adenocarcinoma and Related Lymph Node Metastases: Comparison with Nonmetastatic Barrett's AdenocarcinomaLaboratory Investigation, 2000
- Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal JunctionAnnals of Surgical Oncology, 1999
- C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesionsEuropean Journal of Surgical Oncology, 1998
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosisEuropean Journal of Surgical Oncology, 1997
- Meanings of c-erbB and int-2 Amplification in Superficial Esophageal Squamous Cell CarcinomasThe Annals of Thoracic Surgery, 1996
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987